KOPP, Nadja,LEONG, Justin,MCKENNA, Jeffrey,NDUBAKU, Chudi Obioma,PINZON-ORTIZ, Maria,RONG, Xianhui,SULLIVAN, Ryan
申请号：
AU2019213843
公开号：
AU2019213843A1
申请日:
2019.02.01
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present disclosure relates to a pharmaceutical composition comprising a STING agonist molecule in combination with an IL-15/IL-15Ra complex. The present combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer. Also provided is the use of such a combination for the manufacture of a medicament； the use of such a combination as a medicine； a kit of parts comprising such a combination； and a method of treatment of such a combination.
